Integrative Marker Analysis Allows Risk Assessment for Metastasis in Stage II Colon Cancer

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer

(2011) E C M Zeestraten et al.   BRITISH JOURNAL OF CANCER

Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations

(2011) F. Galimi et al.   CLINICAL CANCER RESEARCH

The candidate tumor suppressor SASH1 interacts with the actin cytoskeleton and stimulates cell–matrix adhesion

(2011) Melanie Martini et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue

(2011) Richard D. Kennedy et al.   JOURNAL OF CLINICAL ONCOLOGY

Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer

(2011) Richard G. Gray et al.   JOURNAL OF CLINICAL ONCOLOGY

Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer

(2011) Gordon Hutchins et al.   JOURNAL OF CLINICAL ONCOLOGY

A Multicenter Study to Validate the Reproducibility of MSI Testing With a Panel of 5 Quasimonomorphic Mononucleotide Repeats

(2010) Ermanno Nardon et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Role of the Serrated Pathway in Colorectal Cancer Pathogenesis

(2010) Barbara Leggett et al.   GASTROENTEROLOGY

Microsatellite Instability in Colorectal Cancer

(2010) C. Richard Boland et al.   GASTROENTEROLOGY

Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

(2010) Ramon Salazar et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular markers to individualize adjuvant therapy for colon cancer

(2010) Tara Gangadhar et al.   Nature Reviews Clinical Oncology

A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy

(2010) V. Deschoolmeester et al.   ONCOLOGIST

Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy

(2009) Ralf Gertler et al.   EUROPEAN JOURNAL OF CANCER

Colon cancer metastasis: MACC1 and Met as metastatic pacemakers

(2009) Franziska Arlt et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data

(2009) Leonard L. Gunderson et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of High-Resolution Melting Analysis as a Diagnostic Tool to Detect the BRAF V600E Mutation in Colorectal Tumors

(2009) Martin Pichler et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

MACC1 — more than metastasis? Facts and predictions about a novel gene

(2009) Ulrike Stein et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Molecular Basis of Colorectal Cancer

(2009) Sanford D. Markowitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognosis of Patients With Colorectal Cancer Is Associated With Lymph Node Ratio

(2008) Robert Rosenberg et al.   ANNALS OF SURGERY

Generalized Maximally Selected Statistics

(2008) Torsten Hothorn et al.   BIOMETRICS

MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis

(2008) Ulrike Stein et al.   NATURE MEDICINE